Biomedical engineers at Rochester, Minn.-based Mayo Clinic are developing an experimental biosensor to continuously monitor indoor air and detect up to 100 biological targets in near real time.
The biosensor is designed to measure targets including influenza, RSV, tuberculosis, mold and allergens, according to an Oct. 20 system news release. Researchers have built a small chip with microscopic channels that breaks a liquid sample into thousands of droplets. If a droplet contains a pathogen, it lights up. The finished biosensor would sample indoor air and produce new results about every 45 minutes.
“If a new virus outbreak occurred, as long as we knew the gene sequence, we could very rapidly adapt our system to detect that virus,” Connie Chang, PhD, a biomedical engineer at the system, said.
The biosensor could be used at nurses’ stations, patient rooms and waiting areas. Researchers are also exploring how AI could interpret biosensor readings alongside airflow and occupancy data and automatically adjust air filtration when risks are detected.